ITRI
Itron, Inc. NASDAQ Listed Nov 5, 1993$81.22
Pre-mkt
$81.15
-0.88%
Mkt Cap $3.6B
52w Low $78.53
4.2% of range
52w High $142.00
50d MA $91.23
200d MA $106.70
P/E (TTM)
12.9x
EV/EBITDA
11.7x
P/B
2.2x
Debt/Equity
0.8x
ROE
18.0%
P/FCF
11.0x
RSI (14)
—
ATR (14)
—
Beta
1.50
50d MA
$91.23
200d MA
$106.70
Avg Volume
1.1M
Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing. The Networked Solutions segment provides a combination of communicating devices, such as smart meters, modules, endpoints, and sensors; network infrastructure; and associated application software for acquiring and transporting application-specific data. The Outcomes segment offers value-added, enhanced software and services for managing, organizing, analyzing, and interpreting data to enhance decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. In addition, it offers implementation, project management, installation, consulting, and post-sale maintenance support services, as well as cloud and software-as-a-service; and extended or customer-specific warranties. It offers its products and services under the Itron brand. The company markets its products directly through its sales force, as well as through indirect sales force consisting of distributors, sales representatives, partners, and meter manufacturer representatives to utilities and municipalities. Itron, Inc. was incorporated in 1977 and is headquartered in Liberty Lake, Washington.
2111 North Molter Road · Liberty Lake, WA 99019 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | BMO | 1.26 | 1.49 | +18.3% | 86.92 | -0.8% | +0.1% | -5.0% | +1.3% | +1.9% | -1.4% | — |
| Feb 17, 2026 | BMO | 2.19 | 2.46 | +12.3% | 89.36 | +10.7% | +7.9% | +3.3% | -0.5% | +0.4% | -4.3% | — |
| Oct 30, 2025 | BMO | 1.48 | 1.54 | +4.1% | 138.18 | -1.4% | -21.1% | -7.9% | +6.5% | -0.2% | +0.6% | — |
| Jul 31, 2025 | BMO | 1.33 | 1.62 | +21.8% | 138.42 | -5.6% | -10.0% | -1.1% | +2.1% | -1.6% | +1.2% | — |
| May 1, 2025 | BMO | 1.30 | 1.52 | +16.9% | 111.29 | -2.8% | -2.9% | +0.2% | -0.6% | -0.8% | -0.3% | — |
| Feb 25, 2025 | BMO | 1.05 | 1.35 | +28.6% | 92.60 | +10.7% | +9.9% | +5.8% | -0.8% | +1.9% | -2.2% | — |
| Oct 31, 2024 | BMO | 1.13 | 1.84 | +62.8% | 103.86 | +6.2% | +7.6% | +0.0% | +2.8% | +2.4% | +3.8% | — |
| Aug 1, 2024 | BMO | 0.96 | 1.21 | +26.0% | 103.44 | +2.7% | +4.5% | -6.4% | -3.7% | +0.4% | -2.7% | — |
| May 2, 2024 | BMO | 0.84 | 1.24 | +47.6% | 91.54 | +6.0% | +9.0% | +7.2% | +0.3% | +0.8% | +0.7% | — |
| Feb 26, 2024 | BMO | 0.75 | 1.23 | +64.0% | 74.93 | +24.6% | +22.1% | -0.5% | +3.4% | -1.6% | +0.5% | — |
| Nov 2, 2023 | BMO | 0.51 | 0.98 | +92.2% | 56.85 | +9.7% | +12.8% | +0.3% | +1.1% | -2.6% | +1.4% | — |
| Aug 3, 2023 | BMO | 0.31 | 0.65 | +109.7% | 76.75 | +2.9% | -0.2% | -6.2% | -3.8% | -0.2% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | TD Cowen | Maintains | Buy → Buy | — | $87.00 | $85.77 | -1.4% | -5.0% | +1.3% | +1.9% | -1.4% | +0.2% |
| Apr 29 | TD Cowen | Reiterates | Buy | $130 | $87.00 | $85.77 | -1.4% | -5.0% | +1.3% | +1.9% | -1.4% | +0.2% |
| Apr 21 | Raymond James | Initiates | Underperform | — | $97.63 | $96.03 | -1.6% | -3.6% | -4.8% | -1.2% | -0.0% | -1.8% |
| Apr 16 | JP Morgan | Maintains | Overweight → Overweight | — | $97.55 | $97.29 | -0.3% | -0.6% | +1.5% | -0.8% | -3.6% | -4.8% |
| Apr 16 | Oppenheimer | Maintains | Outperform → Outperform | — | $97.55 | $97.29 | -0.3% | -0.6% | +1.5% | -0.8% | -3.6% | -4.8% |
| Feb 18 | Baird | Upgrade | Neutral → Outperform | — | $96.43 | $99.02 | +2.7% | +3.3% | -0.5% | +0.4% | -4.3% | +2.8% |
| Feb 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $96.43 | $99.02 | +2.7% | +3.3% | -0.5% | +0.4% | -4.3% | +2.8% |
| Feb 17 | Guggenheim | Downgrade | Buy → Neutral | — | $89.36 | $98.89 | +10.7% | +7.9% | +3.3% | -0.5% | +0.4% | -4.3% |
| Feb 13 | Guggenheim | Downgrade | Buy → Neutral | — | $95.74 | $93.32 | -2.5% | -6.7% | +7.9% | +3.3% | -0.5% | +0.4% |
| Jan 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $98.38 | $98.60 | +0.2% | +0.6% | +0.2% | +1.0% | -1.1% | +1.4% |
| Jan 5 | Johnson Rice | Maintains | Accumulate → Buy | — | $94.47 | $94.80 | +0.3% | +2.4% | +1.0% | -0.4% | +1.2% | +0.9% |
| Nov 4 | Argus | Downgrade | Buy → Hold | — | $106.81 | $104.50 | -2.2% | -0.2% | +0.6% | -1.1% | -0.7% | -4.2% |
| Oct 31 | Baird | Downgrade | Outperform → Neutral | — | $108.99 | $111.70 | +2.5% | -7.9% | +6.5% | -0.2% | +0.6% | -1.1% |
| Oct 16 | JP Morgan | Maintains | Overweight → Overweight | — | $133.72 | $134.77 | +0.8% | +0.4% | -2.2% | +2.1% | -0.3% | -0.9% |
| Oct 7 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $125.94 | $127.90 | +1.6% | +0.5% | +0.8% | -0.7% | -3.5% | +5.0% |
| Jul 31 | JP Morgan | Upgrade | Neutral → Overweight | — | $138.42 | $130.71 | -5.6% | -10.0% | -1.1% | +2.1% | -1.6% | +1.2% |
| Jul 22 | Roth Capital | Maintains | Buy → Buy | — | $136.63 | $137.09 | +0.3% | -1.3% | +0.5% | -1.1% | +1.5% | +0.2% |
| Jul 22 | JP Morgan | Maintains | Neutral → Neutral | — | $136.63 | $137.09 | +0.3% | -1.3% | +0.5% | -1.1% | +1.5% | +0.2% |
| Jul 14 | Guggenheim | Maintains | Buy → Buy | — | $134.54 | $135.18 | +0.5% | +0.6% | +0.2% | +0.4% | +0.4% | -0.2% |
| May 5 | Piper Sandler | Maintains | Neutral → Neutral | — | $108.23 | $107.30 | -0.9% | -0.6% | -0.8% | -0.3% | +1.5% | +0.7% |
| Apr 17 | Guggenheim | Maintains | Buy → Buy | — | $101.65 | $101.56 | -0.1% | +1.6% | -1.7% | +2.6% | +1.3% | +3.5% |
| Feb 27 | Piper Sandler | Maintains | Neutral → Neutral | — | $107.72 | $107.95 | +0.2% | -0.8% | +1.9% | -2.2% | -0.7% | +1.1% |
| Feb 27 | Guggenheim | Maintains | Buy → Buy | — | $107.72 | $107.95 | +0.2% | -0.8% | +1.9% | -2.2% | -0.7% | +1.1% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $101.81 | $104.99 | +3.1% | +5.8% | -0.8% | +1.9% | -2.2% | -0.7% |
| Feb 26 | Oppenheimer | Maintains | Outperform → Outperform | — | $101.81 | $104.99 | +3.1% | +5.8% | -0.8% | +1.9% | -2.2% | -0.7% |
| Nov 6 | Guggenheim | Maintains | Buy → Buy | — | $117.68 | $122.56 | +4.1% | +3.8% | +0.7% | +0.7% | +0.6% | -2.6% |
| Nov 1 | Roth MKM | Maintains | Buy → Buy | — | $111.76 | $112.91 | +1.0% | +0.0% | +2.8% | +2.4% | +3.8% | +0.7% |
| Nov 1 | Baird | Maintains | Outperform → Outperform | — | $111.76 | $112.91 | +1.0% | +0.0% | +2.8% | +2.4% | +3.8% | +0.7% |
| Nov 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $111.76 | $112.91 | +1.0% | +0.0% | +2.8% | +2.4% | +3.8% | +0.7% |
| Nov 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $111.76 | $112.91 | +1.0% | +0.0% | +2.8% | +2.4% | +3.8% | +0.7% |
| Nov 1 | TD Cowen | Maintains | Buy → Buy | — | $111.76 | $112.91 | +1.0% | +0.0% | +2.8% | +2.4% | +3.8% | +0.7% |
| Aug 21 | Roth MKM | Maintains | Buy → Buy | — | $97.15 | $97.69 | +0.6% | +2.4% | +0.7% | +1.8% | -0.3% | +0.0% |
| Aug 5 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $101.15 | $96.72 | -4.4% | -3.7% | +0.4% | -2.7% | +3.8% | -0.3% |
| Aug 2 | Roth MKM | Maintains | Buy → Buy | — | $108.09 | $103.85 | -3.9% | -6.4% | -3.7% | +0.4% | -2.7% | +3.8% |
| Aug 2 | Baird | Maintains | Outperform → Outperform | — | $108.09 | $103.85 | -3.9% | -6.4% | -3.7% | +0.4% | -2.7% | +3.8% |
| Jul 22 | Piper Sandler | Maintains | Neutral → Neutral | — | $101.65 | $102.16 | +0.5% | +2.5% | +2.7% | -4.6% | -0.8% | +2.3% |
| Jul 17 | Oppenheimer | Maintains | Outperform → Outperform | — | $107.43 | $107.43 | +0.0% | -4.2% | -0.4% | -0.8% | +2.5% | +2.7% |
| Jul 16 | Roth MKM | Maintains | Buy → Buy | — | $105.18 | $107.42 | +2.1% | +2.1% | -4.2% | -0.4% | -0.8% | +2.5% |
| Jul 16 | JP Morgan | Maintains | Neutral → Neutral | — | $105.18 | $107.42 | +2.1% | +2.1% | -4.2% | -0.4% | -0.8% | +2.5% |
| Jul 11 | Guggenheim | Upgrade | Neutral → Buy | — | $100.00 | $104.40 | +4.4% | +3.4% | +1.1% | +0.6% | +2.1% | -4.2% |
| Jun 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $102.86 | $102.35 | -0.5% | -4.3% | +0.7% | -0.5% | -1.3% | +0.5% |
| May 21 | Piper Sandler | Downgrade | Overweight → Neutral | — | $109.64 | $107.10 | -2.3% | -2.4% | +0.7% | -0.6% | +2.3% | +0.5% |
| May 6 | Stephens & Co. | Maintains | Equal Weight → Equal Weight | — | $107.01 | $107.43 | +0.4% | +0.3% | +0.8% | +0.7% | -0.5% | -1.1% |
| May 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $99.82 | $102.55 | +2.7% | +7.2% | +0.3% | +0.8% | +0.7% | -0.5% |
| May 3 | TD Cowen | Maintains | Buy → Buy | — | $99.82 | $102.55 | +2.7% | +7.2% | +0.3% | +0.8% | +0.7% | -0.5% |
| May 3 | Roth MKM | Maintains | Buy → Buy | — | $99.82 | $102.55 | +2.7% | +7.2% | +0.3% | +0.8% | +0.7% | -0.5% |
| May 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $99.82 | $102.55 | +2.7% | +7.2% | +0.3% | +0.8% | +0.7% | -0.5% |
| May 3 | Oppenheimer | Maintains | Outperform → Outperform | — | $99.82 | $102.55 | +2.7% | +7.2% | +0.3% | +0.8% | +0.7% | -0.5% |
| Apr 23 | Roth MKM | Maintains | Buy → Buy | — | $91.46 | $91.77 | +0.3% | +3.7% | -0.4% | -0.0% | +1.4% | -0.8% |
| Apr 11 | Piper Sandler | Maintains | Overweight → Overweight | — | $90.49 | $90.78 | +0.3% | +1.9% | -0.8% | -1.6% | +0.9% | -0.3% |
No insider trades available.
8-K · 8.01
!! High
Itron, Inc. -- 8-K 8.01: Material Event / Announcement
Itron's board authorized a $200 million share buyback program over 18 months, signaling management confidence in the stock and potentially benefiting remaining shareholders through reduced share count.
May 8
8-K
Itron Inc -- 8-K Filing
Itron Inc disclosed a securities litigation matter under PSLRA protections while outlining its investigation and remediation efforts regarding an unspecified incident affecting the company.
Apr 24
8-K · 1.01
! Medium
Itron Inc -- 8-K 1.01: Financing / Debt Agreement
Itron secured $700 million in convertible senior notes due 2032 through a private placement, providing debt financing while offering conversion equity upside to qualified institutional investors.
Feb 26
8-K
Itron Inc -- 8-K Filing
I cannot generate a meaningful investment analysis from this excerpt, as it contains only standard forward-looking statement disclaimers without substantive information about a material corporate event affecting Itron Inc.
Feb 17
Data updated apr 25, 2026 4:27pm
· Source: massive.com